Clinical Trial Update: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. [Phase 1, Phase 2]

View source ↗

Summary

Ipsen is conducting a Phase 1/2 study to evaluate IPN10200 for upper limb spasticity in adults, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Upper Limb Spasticity

Drugs mentioned

• IPN10200

Snippet

Sponsor: Ipsen | Conditions: Spasticity | Phase 1, Phase 2 | Status: RECRUITING